Literature DB >> 11383869

Temporal hypometabolism at the onset of cryptogenic temporal lobe epilepsy.

P Matheja1, T Kuwert, P Lüdemann, M Weckesser, C Kellinghaus, G Schuierer, B Diehl, E B Ringelstein, O Schober.   

Abstract

Most patients with intractable temporal lobe epilepsy (TLE) exhibit temporal glucose hypometabolism. The reasons for the development of this abnormality are as yet unclear. The current notion is that an initial injury causes seizures, which in turn give rise to hypometabolism. The aim of this study was to assess whether temporal reductions in glucose metabolism in non-lesional TLE are the result of repeated seizures or whether hypometabolism represents an initial disturbance at the onset of disease. Glucose consumption was assessed with fluorine-18 fluorodeoxyglucose positron emission tomography (18F-FDG PET) in 62 patients with cryptogenic non-refractory TLE in different stages of disease. Twelve subjects without neurological illness served as controls. Patients with onset of epilepsy at least 3 years prior to the PET scan were defined as having chronic TLE. Using this criterion, the whole patient cohort included 27 patients with de novo TLE and 35 patients with chronic TLE. The groups were matched for age and sex. The appearance of high-resolution magnetic resonance images of the brain was unremarkable in all patients. In the total cohort, number, duration and frequency of seizures had a significant relation to the magnitude of hypometabolism. Temporal hypometabolism was exhibited by 26 of the 62 patients (42%), including 8 out of 27 (30%) with newly diagnosed TLE and 18 out of 35 (51%) with chronic TLE. The disturbances were more extensive and more severe in patients with chronic TLE. It is concluded that temporal hypometabolism may already be present at the onset of TLE, but is less frequent and less severe in newly diagnosed than in chronic TLE. The metabolic disturbance correlates with the number of seizures. These findings suggest that an initial dysfunction is present in a considerable number of patients and that hypometabolism is worsened by continuing epileptic activity.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11383869     DOI: 10.1007/s002590100499

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  9 in total

Review 1.  Functional neuroimaging in the preoperative evaluation of children with drug-resistant epilepsy.

Authors:  Sandeep Sood; Harry T Chugani
Journal:  Childs Nerv Syst       Date:  2006-06-24       Impact factor: 1.475

2.  "Magnetic resonance imaging negative positron emission tomography positive" temporal lobe epilepsy: FDG-PET pattern differs from mesial temporal lobe epilepsy.

Authors:  R P Carne; M J Cook; L R MacGregor; C J Kilpatrick; R J Hicks; T J O'Brien
Journal:  Mol Imaging Biol       Date:  2007 Jan-Feb       Impact factor: 3.488

3.  Evolution of cortical metabolic abnormalities and their clinical correlates in Sturge-Weber syndrome.

Authors:  C Juhasz; C E A Batista; D C Chugani; O Muzik; H T Chugani
Journal:  Eur J Paediatr Neurol       Date:  2007-04-03       Impact factor: 3.140

4.  Epilepsy: The future scenario.

Authors:  H V Srinivas
Journal:  Ann Indian Acad Neurol       Date:  2010-01       Impact factor: 1.383

5.  Expression of HIF-1α and MDR1/P-glycoprotein in refractory mesial temporal lobe epilepsy patients and pharmacoresistant temporal lobe epilepsy rat model kindled by coriaria lactone.

Authors:  Yaohua Li; Jianbin Chen; Tianfang Zeng; Ding Lei; Lei Chen; Dong Zhou
Journal:  Neurol Sci       Date:  2014-03-04       Impact factor: 3.307

6.  Computer-Aided Diagnosis and Localization of Lateralized Temporal Lobe Epilepsy Using Interictal FDG-PET.

Authors:  Wesley T Kerr; Stefan T Nguyen; Andrew Y Cho; Edward P Lau; Daniel H Silverman; Pamela K Douglas; Navya M Reddy; Ariana Anderson; Jennifer Bramen; Noriko Salamon; John M Stern; Mark S Cohen
Journal:  Front Neurol       Date:  2013-04-03       Impact factor: 4.003

7.  Enhancing glucose metabolism via gluconeogenesis is therapeutic in a zebrafish model of Dravet syndrome.

Authors:  Rajeswari Banerji; Christopher Huynh; Francisco Figueroa; Matthew T Dinday; Scott C Baraban; Manisha Patel
Journal:  Brain Commun       Date:  2021-01-25

8.  'MRI-negative PET-positive' temporal lobe epilepsy (TLE) and mesial TLE differ with quantitative MRI and PET: a case control study.

Authors:  Ross P Carne; Terence J O'Brien; Christine J Kilpatrick; Lachlan R Macgregor; Lucas Litewka; Rodney J Hicks; Mark J Cook
Journal:  BMC Neurol       Date:  2007-06-24       Impact factor: 2.474

9.  Nuclear Medicine Imaging in Pediatric Neurology.

Authors:  Ümit Özgür Akdemir; Lütfiye Özlem Atay Kapucu
Journal:  Mol Imaging Radionucl Ther       Date:  2016-02-05
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.